Day One, Thursday 3rd December, 2009

09:30 Registration and refreshments

10:00 Opening address from the chair

10:10 Current & emerging trends in the global dermatological market
• Overview of the global dermatology market
• Regional differences in dermatology markets
• Major therapy areas and market segments by value and volume
• Recent trends in treatments and near term developments
• Pharma companies’ activities and interests in dermatology

John McDonald
Director Business Development
Astellas Pharma (Europe)

10:50 Is Psoriasis driving the dermatological market?

Dr Michael Tirant
Psoriasis Specialist
The Psoriasis and Skin Clinic (Australia)

11:30 Morning refreshments

11:50 Psoriasis and the biologics market
• Psoriasis and biological drugs - an overview
• Market dynamics and key drivers
• Future opportunities and challenges

Dr Volker Koscielny
Medical Manager - Rheumatology/Dermatology
Wyeth

12.30 Skin cancer – prevention & detection
• High-SPF sunscreens: are they effective in prevention?
• Skin examination and cancer screening
• Type, location, and extent of the lesions
• Surgical or chemical destruction of the lesions

Prof Jana Hercogová
President, Czech Academy of Dermatology
Chair, Communication Committee, EC International Society of Dermatology

13:10 Networking lunch

14.10 Presentation to be announced

Prof Torello Lotti
MD & Chair, Dermatology Dept., University of Florence
President, International Society of Dermatology

14:30 Androgen receptor antagonists for the topical suppression of sebum production
• The early discovery strategy used to identify novel non-steroidal anti androgen compounds and the results from clinical studies on one compound
• An approach of reducing systemic effects by designing compounds for targeted follicular delivery
• An analysis of the chemical property space of dermatologics

Lorna Mitchell
Medicinal Chemist
Pfizer

15:10 Inflammatory Dermatoses - interlink between skin, brain and immune system
• Psychiatric comorbidity in patients with immune and dermatological disorders
• The role of neuropeptides in the pathophysiology of inflammatory dermatoses
• Novel therapeutic approaches emerging from the field of dermatopsychiatry

Dr Emilio Arbe
Senior Director - Clinical Research
Stiefel Laboratories

15:50 Afternoon refreshments

16:10 Understanding Dermatitis
• Domination by systemic corticosteroids
• New formulations creating generic competition
• Long term treatments for contact dermatitis

Prof Georg Stingl
Department of Dermatology
Medical University of Vienna

16:50 Laser tissue regeneration and laser mediated pain relief
• How low level laser therapy (LLLT) heals wounds and reduces pain
• Applications – Non-healing wounds, post operative inflammation and pain
• Evidence – LLLT clinical trials (RCT’s) and comparisons with NSAID’s
• Demonstration (Video)

James Carroll
Founder & CEO
THOR Photomedicine

17:30 Closing remarks from the chair

17:35 Networking drinks
Take your discussions further and build new relationships in a relaxed and informal setting
 

Day Two, Friday 4th December, 2009 

09:30 Registration and refreshments

10:00 Opening address from the chair

10:10 Trends in cosmetic development in EMEA
• Trends in new formulations in cosmetics
• Impact of the new EU regulations on cosmetics development
• Natural versus chemical: what is the future?

Line Vivier
EMEA Franchise Manager
Stiefel Laboratories

10:50 Toxicology in consumer health care and dermatology business
• Safety assessment in this ever changing regulatory world
• How to define the risk threshold in dermatology treatments
• Predictive toxicology in current dermatology new treatments

Marc Princivalle
Head of Risk Assessment EMEA - Director of Toxicology
Stiefel Laboratories

11:30 Morning refreshments

11:50 Regulatory compliances for cosmetic dermatology
• Shared regulation for Botox and dermal fillers
• Proposed deregulation to proportionate regulation for cosmetic class 3b/4 lasers/intense pulse lights
• GMP for cosmetic dermatology/treatments

Sally Taber
Director
Independent Healthcare Advisory Services

12:30 Evaluating technologies for cosmetic dermatology
• Use of imaging systems to evaluate skin
• Imaging systems in clinical trials
• Claim support dilemmas
• Correlation of data
• Nematodes - how not to annoy advertising authorities and consultants

Dr Theresa M. Callaghan
Independent Consultant – Dermatology

13:10 Networking lunch

14.10 Non-invasive skin care & active cosmetics
• Role of skin care actives- moisturisation, photoprotection and anti-aging
• Non- invasive procedures (skin peels, microdermabrasion) in conjunction with skin care actives
• Understanding the market for active cosmetics in the developing world

Harish Mahalingam
Associate Director, Global Medical Affairs
Novartis Consumer Health

14:30 BOTOX – Getting deeper into the aesthetics business
• Analysing the unprecedented success of Botox globally
• Looking ahead – the future of Botox
• Alternatives to BOTOX - Can it be replaced by the Argireline?

15:10 Hair disorders
• Alopecia – unraveling predisposition to pattern hair loss
• New ingredients – new hope?
• Links between skin and hair – how can problems with your skin affect your hair?

Gill Westgate
Honorary Senior Visiting Lecturer, Centre for Skin Sciences, Bradford University
Director, Westgate Consultancy

15:50 Afternoon refreshments

16:10 Cosmetic dermatology & medical ethics
• Does it meet the ethical values?
• Challenges: safety and long-term efficacy of cosmetic surgery procedures
• How is it driving the consumer desire?
Panel members will be drawn from the speakers who take part on day one or day two. If you would like to submit a question to the panel, please email it to: maninder.paul@visiongainglobal.com

16.50 Future trends in dermatology towards 2015
Expert Rater Assisted Symptom Evaluation (ERASE): a novel web-based technique to confirm diagnosis and enhance signal detection in randomised, controlled trials

Joep Schoemaker
Senior Clinical Project Scientist
Schering Plough Research Institute

17:30 Chair’s closing remarks

17:40 End of Conference